Alpha Cognition DD For those into the biotech and phara space Alpha Cognition Inc. ( $ACOG.V ACOGF) is a company you should check out.
$ACOG is in the clinical stages of developing medicines for the treatment of Alzheimer's Disease, ALS, and other under-served neurodegenerative diseases.
Their Alpha-1062 drug helps with the cognitive effects for Alzheimer's. Alpha-1062 similar to a drug that was developed by J&J and approved in the mid-2000s but had serious side-effects which made the drug impossible to handle for many patients. However, $ACOG's version of the drugs is optimized to minimize side effects.
$ACOG is also developing a pro granulin gene therapy drug called Alpha-602. This drug has been shown to help with a number of ALS disease states and may possibly become a curative option.
The cash status of $ACOG is solid which the company having $14.4M from their Canadian IPO to use for the commercialization of Alpha-1062 and Alpha-602.
$ACOG closed about 4% down today at $0.95 so it might be a good time to invest on the cheap
It's MC is $58.422M